Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1172 ARTÍCULOS , VIENDO DEL 1036 AL 1050

Induction of Alzheimer's-like changes in brain of mice expressing mutant APP fed excess methionine

McCampbell A, Wessner K, Marlatt MW, Wolffe C, Toolan D, Podtelezhnikov A, Yeh S, Zhang R, Szczerba P, Tanis KQ, Majercak J, Ray WJ, Savage M.

J Neurochem. 2011 Jan;116(1):82-92. doi: 10.1111/j.1471-4159.2010.07087.x. Epub 2010 Dec 2.

Hsp90 regulates tau pathology through co-chaperone complexes in Alzheimer's disease

Salminen A, Ojala J, Kaarniranta K, Hiltunen M, Soininen H.

Prog Neurobiol. 2011 Jan;93(1):99-110. doi: 10.1016/j.pneurobio.2010.10.006. Epub 2010 Nov 5.

Natural products as a source of Alzheimer's drug leads

Williams P, Sorribas A, Howes MJ.

Nat Prod Rep. 2011 Jan;28(1):48-77. doi: 10.1039/c0np00027b. Epub 2010 Nov 12.

Advances in perfusion magnetic resonance imaging in Alzheimer's disease

Chen W, Song X, Beyea S, D'Arcy R, Zhang Y, Rockwood K.

Alzheimers Dement. 2011 Mar;7(2):185-96. doi: 10.1016/j.jalz.2010.04.004. Epub 2010 Nov 11.

Presenilin-1 but not amyloid precursor protein mutations present in mouse models of Alzheimer's disease attenuate the response of cultured cells to γ-secretase modulators regardless of their potency and structure

Hahn S, Brüning T, Ness J, Czirr E, Baches S, Gijsen H, Korth C, Pietrzik CU, Bulic B, Weggen S.

J Neurochem. 2011 Feb;116(3):385-95. doi: 10.1111/j.1471-4159.2010.07118.x. Epub 2010 Dec 13.

Biochemical, neuropathological, and neuroimaging characteristics of early-onset Alzheimer's disease due to a novel PSEN1 mutation

Ringman JM, Gylys KH, Medina LD, Fox M, Kepe V, Flores DL, Apostolova LG, Barrio JR, Small G, Silverman DH, Siu E, Cederbaum S, Hecimovic S, Malnar M, Chakraverty S, Goate AM, Bird TD, Leverenz JB.

Neurosci Lett. 2011 Jan 10;487(3):287-92. doi: 10.1016/j.neulet.2010.10.039. Epub 2010 Nov 19.

Roles of β-adrenergic receptors in Alzheimer's disease: implications for novel therapeutics

Yu JT, Wang ND, Ma T, Jiang H, Guan J, Tan L.

Brain Res Bull. 2011 Feb 1;84(2):111-7. doi: 10.1016/j.brainresbull.2010.11.004. Epub 2010 Dec 1.

Neuroprotective strategies involving ROS in Alzheimer disease

Dumont M, Beal MF.

Free Radic Biol Med. 2011 Sep 1;51(5):1014-26. doi: 10.1016/j.freeradbiomed.2010.11.026. Epub 2010 Dec 1.

Secretases as therapeutic targets for Alzheimer's disease

Woo HN, Baik SH, Park JS, Gwon AR, Yang S, Yun YK, Jo DG.

Biochem Biophys Res Commun. 2011 Jan 7;404(1):10-5. doi: 10.1016/j.bbrc.2010.11.132. Epub 2010 Dec 3.

Investigation of 15 of the top candidate genes for late-onset Alzheimer's disease

Belbin O, Carrasquillo MM, Crump M, Culley OJ, Hunter TA, Ma L, Bisceglio G, Zou F, Allen M, Dickson DW, Graff-Radford NR, Petersen RC, Morgan K, Younkin SG.

Hum Genet. 2011 Mar;129(3):273-82. doi: 10.1007/s00439-010-0924-2. Epub 2010 Dec 4.

Neurotherapeutic applications of nanoparticles in Alzheimer's disease

Sahni JK, Doggui S, Ali J, Baboota S, Dao L, Ramassamy C.

J Control Release. 2011 Jun 10;152(2):208-31. doi: 10.1016/j.jconrel.2010.11.033. Epub 2010 Dec 4.

Calcineurin inhibition with FK506 ameliorates dendritic spine density deficits in plaque-bearing Alzheimer model mice

Rozkalne A, Hyman BT, Spires-Jones TL.

Neurobiol Dis. 2011 Mar;41(3):650-4. doi: 10.1016/j.nbd.2010.11.014. Epub 2010 Dec 4.

γ-Secretase modulators as potential disease modifying anti-Alzheimer's drugs

Oehlrich D, Berthelot DJ, Gijsen HJ.

J Med Chem. 2011 Feb 10;54(3):669-98. doi: 10.1021/jm101168r. Epub 2010 Dec 9.

Genistein ameliorates learning and memory deficits in amyloid β(1-40) rat model of Alzheimer's disease

Bagheri M, Joghataei MT, Mohseni S, Roghani M.

Neurobiol Learn Mem. 2011 Mar;95(3):270-6. doi: 10.1016/j.nlm.2010.12.001. Epub 2010 Dec 7.

The cholinergic system in aging and neuronal degeneration

Schliebs R, Arendt T.

Behav Brain Res. 2011 Aug 10;221(2):555-63. doi: 10.1016/j.bbr.2010.11.058. Epub 2010 Dec 9.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias